These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31741178)

  • 1. Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.
    Liu CC; Takeuchi H
    CNS Drugs; 2020 Feb; 34(2):117-126. PubMed ID: 31741178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Eur Psychiatry; 2023 Aug; 66(1):e66. PubMed ID: 37578111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Psychol Med; 2023 Nov; 53(15):7078-7086. PubMed ID: 36896797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
    Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
    BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
    Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
    Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
    Zipursky RB; Menezes NM; Streiner DL
    Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders.
    Crellin NE; Priebe S; Morant N; Lewis G; Freemantle N; Johnson S; Horne R; Pinfold V; Kent L; Smith R; Darton K; Cooper RE; Long M; Thompson J; Gruenwald L; Freudenthal R; Stansfeld JL; Moncrieff J
    BMC Psychiatry; 2022 Mar; 22(1):185. PubMed ID: 35291964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
    Thompson A; Singh S; Birchwood M
    Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review.
    Moncrieff J; Crellin NE; Long MA; Cooper RE; Stockmann T
    Schizophr Res; 2020 Nov; 225():47-54. PubMed ID: 31604607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
    Di Capite S; Upthegrove R; Mallikarjun P
    Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.